Esperoct 1 UNT Injection

RxCUI
2275729
RxNorm name
Esperoct 1 UNT Injection
Display name
Esperoct 1 UNT Injection
Full name
Esperoct 1 UNT Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
125671EsperoctAntihemophilic Factor (Recombinant), GlycoPEGylated-exei351(a)Rx2026-10-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
ESPEROCTANTIHEMOPHILIC FACTOR (RECOMBINANT), GLYCOPEGYLATED-EXEINovo Nordisk562f94e8-825f-4d7f-b93c-b783ac3a43bc2024-07-01Warnings, Adverse reactionsExact identifier
rxcui: 2275729

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
562f94e8-825f-4d7f-b93c-b783ac3a43bcESPEROCT 1 UNT Injection [PSN] · antihemophilic factor (recombinant) pegylated-exei 1 UNT Injection [Esperoct] [SBD] · Esperoct 1 UNT Injection [SY]37These highlights do not include all the information needed to use ESPEROCT ® safely and effectively. See full prescribing information for ESPEROCT. ESPEROCT [antihemophilic factor (recombinant), glycopegylated-exei] lyophilized powder for solution, for intravenous use Initial U.S. Approval: 201920240701